Amcor plc
43.13USD
-1.2100 (-2.73%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1▲ | $0 | 0 | 0 |
| Next quarter | $0.87▲ | $0 | 0 | 0 |
| Current year | $4.04▲ | $0 | 0 | 0 |
| Next year | $4.36▲ | $0 | 0 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2025-12-31 | $0.84 | $0.86 | +0.02 (+2.5%) |
| 2025-09-30 | $0.92 | $0.97 | +0.05 (+4.9%) |
| 2025-06-30 | $1.08 | $1 | -0.08 (-7.2%) |
| 2025-03-31 | $0.91 | $0.9 | -0.01 (-1.3%) |
58 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Downgraded from Overweight | Neutral | $44 $47 | Aug 17, 2026 |
| Citigroup | Maintained | Buy | $47 $52 | Aug 14, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $43 $44 | Aug 14, 2026 |
| UBS | Initiated | Buy | $56 | Aug 11, 2026 |
| Jefferies | Downgraded from Buy | Hold | — | Jul 22, 2026 |
| BMO Capital | Initiated from Outperform | Market Perform | $47 | Jul 17, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $41 $43 | Jul 15, 2026 |
| B of A Securities | Maintained | Buy | $48 $51 | Jul 14, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $43 $41 | May 20, 2026 |
| Citigroup | Maintained | Buy | $54 $47 | May 8, 2026 |
| JP Morgan | Maintained | Overweight | $50 $44 | May 7, 2026 |
| Truist Securities | Reiterated | Buy | $50 $51 | May 7, 2026 |
| Truist Securities | Maintained | Buy | $60 $50 | Apr 15, 2026 |
| Deutsche Bank | Initiated from Hold | Buy | $50 | Apr 1, 2026 |
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $48 $43 | Mar 20, 2026 |
| Citigroup | Maintained | Neutral | $50 $54 | Feb 12, 2026 |
| Wells Fargo | Maintained | Overweight | $9 $48 | Jan 20, 2026 |
| Baird | Upgraded from Neutral | Outperform | $10 | Jan 7, 2026 |
| Truist Securities | Maintained | Buy | $11 $12 | Jan 6, 2026 |
| Wells Fargo | Maintained | Overweight | $11 $9 | Oct 15, 2025 |
| Baird | Maintained | Neutral | $11 $10 | Aug 15, 2025 |
| Wells Fargo | Maintained | Overweight | $10 $11 | Jul 18, 2025 |
| Truist Securities | Maintained | Buy | $12 $11 | Jul 11, 2025 |
| Jefferies | Initiated | Buy | $12 | Jul 2, 2025 |
| UBS | Upgraded from Neutral | Buy | — | Jun 26, 2025 |
6 filings from 2 insiders · 0 buy / 0 sell over 6m
Officers and directors of AMCR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Konieczny PeterOfficer, Chief Executive Officer | GrantRestricted Stock Units | 11.1k | — | — | Sep 3, 2026 |
| Konieczny PeterOfficer, Chief Executive Officer | Tax | 590 | $46.68 | $28k | Sep 3, 2026 |
| Konieczny PeterOfficer, Chief Executive Officer | Exercise | 11.1k | — | — | Sep 3, 2026 |
| Wilson IanOfficer, EXECUTIVE VICE PRESIDENT | ExerciseRestricted Stock Units | 5.8k | — | — | Sep 2, 2026 |
| Wilson IanOfficer, EXECUTIVE VICE PRESIDENT | Tax | 514 | $45.82 | $24k | Sep 2, 2026 |
| Wilson IanOfficer, EXECUTIVE VICE PRESIDENT | Exercise | 5.8k | — | — | Sep 2, 2026 |
No analyst notes on AMCR yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 6 | 7 | 0 | 0 | Buy2.43 |
| 1 mo ago | 2 | 5 | 6 | 0 | 0 | Buy2.31 |
| 2 mo ago | 1 | 7 | 4 | 0 | 0 | Buy2.25 |